[CAS NO. 196597-26-9]  Ramelteon

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [196597-26-9]

Distributor
Catalog
SLK-S1259
Brand
Selleck
CAS
196597-26-9

DESCRIPTION [196597-26-9]

Overview

MDLMFCD08067736
Molecular Weight259.34
Molecular FormulaC16H21NO2
SMILESC(CNC(CC)=O)[C@H]1C=2C3=C(C=CC2CC1)OCC3

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM3.8559 mL19.2797 mL38.5594 mL
5 mM0.7712 mL3.8559 mL7.7119 mL
10 mM0.3856 mL1.9280 mL3.8559 mL
50 mM0.0771 mL0.3856 mL0.7712 mL

Description

Ramelteon (TAK-375) is a novel agonist for human MT1 and MT2 receptors and chick forebrain melatonin receptors with of 14 pM, 112 pM and 23.1 pM, respectively.

Features

A tricyclic synthetic analog of melatonin.

Targets

MT1 receptor [1]
(Cell-free assay)
MT receptor (chicken) [1]
(Cell-free assay)
MT2 receptor [1]
(Cell-free assay)
14 pM(Ki)23.1 pM(Ki)112 pM(Ki)

In vitro

Ramelteon inhibits forskolin-stimulated cAMP production with IC50 of 21.2 pM in CHO cells. Ramelteon has high affinity with recombinant human MT1 and MT2 receptors with pKi of 10.05 and 9.70, respectively. Ramelteon inhibits Xenopus laevis melanophore pigment granule aggregation with pEC50 of 11.48. Ramelteon (1 nM) increases ERK1/2 phosphorylation not only in MT1/MT2 cerebellar granule cells but also in cerebellar granule cells expressing only one of the two melatonin receptors. 4P-PDOT blocks the stimulatory action of Ramelteon (1 nM) in MT1 KO cerebellar granule cells, while luzindole attenuates the action of Ramelteon (1 nM) in MT2 KO cerebellar granule cells. Ramelteon (100 μM) induces any pigment dispersion while melatonin completely disperses aggregated melanophores at 10 μM.

In vivo

Ramelteon (10 mg/kg, i/p) significantly reduces NREM sleep latency in rat and also produces a short-lasting increase in nonrapid eye movement (NREM) sleep duration, but the NREM power spectrum is unaltered. Ramelteon (0.1 mg/kg and 1 mg/kg, p.o.) accelerates reentrainment of running wheel activity rhythm to the new lightdark cycle in rats without affecting learning or memory. Ramelteon (0.03 mg/kg and 0.3 mg/kg, p.o.) significantly shortens latency to sleep onset and significantly increases total duration of sleep in freely moving monkeys without affecting the general behavior of the monkeys.


Synonyms

Propanamide, N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]-
Propanamide, N-[2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]-, (S)-
N-[2-[(8S)-1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]propanamide
TAK 375
Ramelteon
(S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]propionamide
Rozerem
(S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide
Rozerm